Idorsia Ltd (IDIA.SW)
CHF 1.49
(15.5%)
CHF 1.49
(15.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.2 Billion CHF | -1.93% |
| 2022 | 1.22 Billion CHF | 5.49% |
| 2021 | 1.16 Billion CHF | 82.37% |
| 2020 | 637.98 Million CHF | 1.06% |
| 2019 | 631.32 Million CHF | 10.6% |
| 2018 | 570.84 Million CHF | 56.53% |
| 2017 | 364.68 Million CHF | 24.29% |
| 2016 | 293.42 Million CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.26 Billion CHF | 0.32% |
| 2024 Q1 | 1.26 Billion CHF | 4.79% |
| 2024 Q3 | 961.85 Million CHF | -0.5% |
| 2023 Q3 | 1.2 Billion CHF | -2.58% |
| 2023 Q4 | 1.2 Billion CHF | -0.14% |
| 2023 FY | 1.2 Billion CHF | -1.93% |
| 2023 Q1 | 1.22 Billion CHF | -0.19% |
| 2023 Q2 | 1.23 Billion CHF | 0.99% |
| 2022 Q2 | 1.2 Billion CHF | 0.36% |
| 2022 Q4 | 1.22 Billion CHF | 2.24% |
| 2022 FY | 1.22 Billion CHF | 5.49% |
| 2022 Q1 | 1.19 Billion CHF | 2.96% |
| 2022 Q3 | 1.2 Billion CHF | -0.15% |
| 2021 Q1 | 637.83 Million CHF | -0.02% |
| 2021 FY | 1.16 Billion CHF | 82.37% |
| 2021 Q4 | 1.16 Billion CHF | -7.34% |
| 2021 Q3 | 1.25 Billion CHF | 96.66% |
| 2021 Q2 | 638.49 Million CHF | 0.1% |
| 2020 FY | 637.98 Million CHF | 1.06% |
| 2020 Q1 | 631.79 Million CHF | 0.07% |
| 2020 Q2 | 632.81 Million CHF | 0.16% |
| 2020 Q3 | 634.03 Million CHF | 0.19% |
| 2020 Q4 | 637.98 Million CHF | 0.62% |
| 2019 Q2 | 630.37 Million CHF | 1.03% |
| 2019 FY | 631.32 Million CHF | 10.6% |
| 2019 Q4 | 631.32 Million CHF | -0.03% |
| 2019 Q1 | 623.92 Million CHF | 9.3% |
| 2019 Q3 | 631.53 Million CHF | 0.18% |
| 2018 Q1 | 366.57 Million CHF | 0.52% |
| 2018 FY | 570.84 Million CHF | 56.53% |
| 2018 Q3 | 568.81 Million CHF | 54.36% |
| 2018 Q2 | 368.48 Million CHF | 0.52% |
| 2018 Q4 | 570.84 Million CHF | 0.36% |
| 2017 Q1 | 296.88 Million CHF | 0.0% |
| 2017 FY | 364.68 Million CHF | 24.29% |
| 2017 Q4 | 364.68 Million CHF | 0.53% |
| 2017 Q3 | 362.76 Million CHF | 0.5% |
| 2017 Q2 | 360.95 Million CHF | 21.58% |
| 2016 FY | 293.42 Million CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Addex Therapeutics Ltd | 344.33 Thousand CHF | -349449.858% |
| BB Biotech AG | 304.9 Million CHF | -294.761% |
| Basilea Pharmaceutica AG | 128.6 Million CHF | -835.902% |
| Evolva Holding SA | - CHF | -Infinity% |
| Kuros Biosciences AG | 5.51 Million CHF | -21712.722% |
| Molecular Partners AG | 3.65 Million CHF | -32857.996% |
| Relief Therapeutics Holding AG | 4.31 Million CHF | -27819.879% |
| Santhera Pharmaceuticals Holding AG | 25.06 Million CHF | -4702.594% |